BioMed Realty Trust, Inc. (BMR) Tops Q2 FFO by 3c
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.32, $0.03 better than the analyst estimate of $0.29. Revenue for the quarter came in at $124.8 million versus the consensus estimate of $118.98 million.
BioMed Realty Trust, Inc. sees FY2012 FFO of $1.20-$1.28, versus the consensus of $1.24.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
BioMed Realty Trust, Inc. sees FY2012 FFO of $1.20-$1.28, versus the consensus of $1.24.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
